Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine–Benzenesulfonamide Compounds
Molecules · 09.10.2024 · 29 (19) · 4778
DOI: 10.3390/molecules29194778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 09.10.2024. Verfasst von Abdalrahman Khalifa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Prairie View A&M University, Prairie View, TX 77446, USA. Hauptthemen laut MEDLINE: Sulfonamides, Benzenesulfonamides, Microbial Sensitivity Tests, Drug Design. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial infection poses a serious threat to human life due to the rapidly growing resistance of bacteria to antibacterial drugs, which is a significant public health issue. This study was focused on the design and synthesis of a new series of 25 analogues bearing a 5-cyano-6-oxo-4-substituted phenyl-1,6-dihydropyrimidine scaffold hybridized with different substituted benzenesulfonamides through the thioacetamide linker M1–25. The antimicrobial activity of the new molecules was studied against various Gram-positive, Gram-negative, and fungal strains. All the tested compounds showed promising broad-spectrum antimicrobial efficacy, especially against K. pneumoniae and P. aeruginosa. Furthermore, the most promising compounds, 6M, 19M, 20M, and 25M, were subjected to minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. In addition, the antivirulence activity of the compounds was also examined using multiple biofilm assays. The new compounds promisingly revealed the suppression of microbial biofilm formation in the examined K. pneumoniae and P. aeruginosa microbial isolates. Additionally, in silico ADMET studies were conducted to determine their oral bioavailability, drug-likeness characteristics, and human toxicity risks. It is suggested that new pyrimidine–benzenesulfonamide derivatives may serve as model compounds for the further optimization and development of new antimicrobial and antisepsis candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Prairie View A&M University, Prairie View, TX 77446, USA.
- Department of Chemistry, Texas A&M University, College Station, TX 77843, USA.
- Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo P.O. Box 12622, Egypt.
- Microbiology and Immunology Department, Faculty of Pharmacy, O6U, Giza P.O. Box 12585, Egypt.
- Green Chemistry Department, Chemical Industries Research Institute, National Research Centre, Cairo P.O. Box 12622, Egypt.
ORCID-Profile: Walaa A Alshareef, Eman A El-Gebaly, Samia A Elseginy, Sameh H Abdelwahed
Zitieren
APA
Khalifa, A., Anwar, M. M., Alshareef, W. A., El-Gebaly, E. A., Elseginy, S. A., & Abdelwahed, S. H. (2024). Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine–Benzenesulfonamide Compounds. Molecules, 29(19), 4778. https://doi.org/10.3390/molecules29194778
Vancouver
Khalifa A, Anwar MM, Alshareef WA, El-Gebaly EA, Elseginy SA, Abdelwahed SH. Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine–Benzenesulfonamide Compounds. Molecules. 2024;29(19):4778. doi:10.3390/molecules29194778
BibTeX
@article{Khalifa2024,
author = {Khalifa, Abdalrahman and Anwar, Manal M and Alshareef, Walaa A and El-Gebaly, Eman A and Elseginy, Samia A and Abdelwahed, Sameh H},
title = {Design, Synthesis, and Antimicrobial Evaluation of New Thiopyrimidine–Benzenesulfonamide Compounds},
journal = {Molecules},
year = {2024},
volume = {29},
number = {19},
pages = {4778},
doi = {10.3390/molecules29194778}
}
EUVIMED